These drugs work by mimicking the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety
Appetite suppression is often strongest in the first part of the day, and many patients tell me they're simply not hungry which creates a real risk of under-eating protein and starting the day in a deficit they don't recover from by dinner
Some of these studies are happening at VCU
It is known that women are diagnosed with an anxiety disorder twice as likely as men, and the GLP-1 pathway may be involved in this dependence
This sustained activation of GLP-1 pathways leads to measurable changes in eating behavior and metabolic rate within the first two to four weeks of treatment
Purpose-built for physicians GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes Key takeaways: People with type 2 diabetes using a GLP-1 medication have a lower risk for most obesity-associated cancers than insulin users
